Company news

Ezz Life Science Holdings Ltd. (ASX:EZZ) news

Ezz Life Science Holdings Ltd. news releases on 6ix. Latest, Apr 30, 2026: Quarterly Activity and Cashflow Report

View Ezz Life Science Holdings Ltd. →

Press releases & updates

Quarterly Activity and Cashflow Report

April 30, 2026

Half Yearly Report and Accounts

February 27, 2026

EZZ:EZZ Appoints Aumake in $10m Exclusive Dist Agreement

February 16, 2026

$10m Exclusive Dist Agreement with EZZ Life Sciences

February 16, 2026

Quarterly Activities/Appendix 4C Cashflow Report

January 30, 2026

Final Dividend Announcement

November 4, 2025

Appendix 4E - Preliminary Final Report

August 29, 2025

Quarterly Activities / Appendix 4C Cashflow Report

July 28, 2025

EZZ Enters SE Asia with Multi Year Distribution Agreement

June 9, 2025

Interim Dividend Announcement

May 5, 2025

EZZ Appoints United States Manufacturing Partner

March 10, 2025

Quarterly Activities/Appendix 4C Cash Flow Report

January 22, 2025

Response to ASX Aware Letter

September 23, 2024

FY24 Results Presentation

August 27, 2024

FY24 Full Year Results Summary

August 27, 2024

Preliminary Final Report

August 27, 2024

EZZ Expands Portfolio with 4 Functional Food Products

August 5, 2024

EZZ Targets US Expansion Receives Product Approvals from FDA

June 24, 2024

EZZ Secures Major Sales Agreement with Pinehills (HK) Ltd

May 30, 2024

Half Year Interim Dividend

May 6, 2024

EZZ Completes Private Placement with Strategic Investor

April 11, 2024

Investor Presentation 1H FY24 and Market Update

March 26, 2024

FY23 (unaudited) Results Presentation

August 28, 2023

EZZ announces Major Distribution Agreement with HIC

May 8, 2023

EZZ launches Amazon online store and new product releases

March 29, 2023

Updated Appendix 4C

November 18, 2022

FY22 Results Presentation

October 12, 2022

Dividend Details

October 11, 2022

FY22 Financial Results Commentary

September 30, 2022

EZZ establishes international store on Douyin

May 9, 2022

1H FY22 Results Presentation

March 15, 2022

EZZ Life Science : Application for quotation of securities - EZZ

December 14, 2021

Supplementary Announcement to Appendix 3Y

October 12, 2021

Correction to information presented by former CEO

October 12, 2021

Trading Halt

October 10, 2021

Resignation of CEO and Executive Director

October 8, 2021

FY21 Financial Results Commentary

September 30, 2021

Appendix 4E and Preliminary Final Report

August 31, 2021

EZZ Q4 FY21 Investor Briefing

August 23, 2021

EZZ secures long-term EAORON contract pricing

June 8, 2021

Appendix 4C - quarterly

April 30, 2021